RICARDO
RUIZ VILLAVERDE
Instituto de Investigación Biosanitaria de Granada
Granada, EspañaPublications en collaboration avec des chercheurs de Instituto de Investigación Biosanitaria de Granada (4)
2022
-
Factors associated with adverse reactions to BNT162b2 COVID-19 vaccine in a cohort of 3969 hospital workers
Vaccines, Vol. 10, Núm. 1
-
Risankizumab: Efficacy, Safety, and Survival in the Mid-Term (52 Weeks) in Real Clinical Practice in Andalusia, Spain, According to the Therapeutic Goals of the Spanish Psoriatic Guidelines
Life, Vol. 12, Núm. 11
2021
-
Exfoliative cheilitis, a condition with an easy diagnosis but difficult treatment
Piel, Vol. 36, Núm. 8, pp. 575-576